Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to syncytial: respiratory syncytial virus


n. pl. syn·cy·ti·a (-sĭsh′ē-ə)
A multinucleated mass of cytoplasm that is not separated into individual cells.

[New Latin : syn- + cyt(o)- + -ium.]

syn·cy′ti·al (-sĭsh′ē-əl) adj.


a. sincitial, rel. a un sincitio o que lo constituye.
References in periodicals archive ?
Respiratory syncytial virus (RSV) is the major cause of acute lower respiratory tract infections in young children, but very little is known about its epidemiology and circulating genotypes in Pakistan.
Regarding an earlier announcement on a cluster of patients infected with Respiratory Syncytial Virus in an infirmary ward, the spokesperson for Pok Oi Hospital gave the following update today (July 26):
M2 PHARMA-June 29, 2017-FDA Grants Clearance and CLIA Waiver to Quidel for Sofia 2 Instrument for Use with Respiratory Syncytial Virus Assay
MedImmune, AstraZeneca's biologics research and development unit, and France-based Sanofi Pasteur have agreed to collaborate to develop a monoclonal antibody treatment for respiratory syncytial virus, it was reported yesterday.
Global Markets Direct's, 'Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2016', provides an overview of the Respiratory Syncytial Virus (RSV) Infections pipeline landscape.
USPRwire, Tue Aug 18 2015] Global Markets Direct's, 'Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2015', provides an overview of the Respiratory Syncytial Virus (RSV) Infections's therapeutic pipeline.
Objective: To evaluate the histopathological parameters of the placenta like weight, infarct and syncytial knots, at different maternal hemoglobin levels, in both qualitative and quantitative manner.
All the important histological features such as fibrin deposition, villous pattern, syncytial knots, infarction, calcification, stromal fibrosis were noted in placentae.
Human respiratory syncytial virus (RSV) is the major viral cause of bronchiolitis and pneumonia in infants and also a major cause of severe respiratory illness in the elderly (1).
BASEL, Switzerland -- Okairos today announced the initiation of a Phase I clinical trial evaluating a vaccine against respiratory syncytial virus (RSV), a leading cause of hospital admissions in infants and children.
Respiratory syncytial virus: presentation, treatment and prevention of a neonatal intensive care unit outbreak in Lima
It is well known that respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infection (RTI) and bronchiolitis in infants and young children.